Companies: 10,795·Total market cap: $144.5T
Pfizer Inc.

Pfizer Inc.

PFENYSEHealthcare● Active
$25.61
$-0.43(-1.65%)
Market Cap$146.0B
P/E Ratio
52W High$28.75
52W Low$23.08
Overview

Pfizer Inc. (PFE) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

pfe · stock forecast · 39 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 39 Wall Street analysts in the past 3 months

SellBuy

Hold

39 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
16
Hold
21
Sell
2
Strong Sell
0
Total: 39 · Buy rate: 41.0%

12-Month Price Target

High

$30.00

Consensus

$27.00

+5.0% upside

Low

$25.00

Median: $27 · Last Close: $25.70

The Pfizer Inc. (PFE) analyst consensus is Hold, based on ratings from 39 Wall Street analysts over the past 3 months. The average 12-month PFE price target is $27.00, representing +5.0% upside from the current price of $25.70.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $27 (5.0%)

Consensus Target

$27.00

5.0% upside

High Target

$30

16.7%

Low Target

$25

-2.7%

Current Price

$25.70

as of today

Based on analyst price targets, the PFE stock price prediction for the next 12 months ranges from $25 to $30. The consensus PFE price forecast of $27.00 implies 5.0% upside from the current price of $25.70.

Short-Term Price Prediction

Ranging

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$25.600.40%

1-day model range: $25.56–$25.64. Peak: $25.64 (-0.40%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$21-17.9%
2028$19-27.4%
2029$17-32.9%
2030$16-36.2%
2031-38.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%
1Buy
1Neutral
12Sell
RSI (14)56.1Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · PFE · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$25.67BUY
MA 10$25.83SELL
MA 20$25.78SELL
MA 50$26.55SELL
MA 100$26.67SELL
MA 200$25.85SELL
Current $PFE · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$25.76SELL
EMA 10$25.79SELL
EMA 20$25.90SELL
EMA 50$26.26SELL
EMA 100$26.30SELL
EMA 200$26.07SELL
Current $PFE · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Citigroup2026-04-29
Maintains
NeutralNeutral
RBC Capital2026-04-20
Maintains
UnderperformUnderperform
UBS2026-04-13
Maintains
NeutralNeutral
Morgan Stanley2026-04-10
Maintains
Equal WeightEqual Weight
B of A Securities2026-04-09
Maintains
NeutralNeutral
Guggenheim2026-03-24
Maintains
BuyBuy
HSBC2026-03-17
Maintains
BuyBuy
Argus Research2026-03-02
Upgrade ↑
HoldBuy
Freedom Broker2026-02-09
Maintains
BuyBuy
Cantor Fitzgerald2026-02-04
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Pfizer Inc. (PFE) stock. Of the recent 293 rating actions, 21 were upgrades and 29 were downgrades. 39 analysts currently cover PFE.

Analyst Recommendation Trends

Buy ratings101
Hold ratings04↑ +4
Sell ratings01↑ +1

PFE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$61.7B

↑ 12.9% YoY

Revenue Next Year

$59.2B

↓ 4.1% YoY

EPS This Year

$2.96

EPS Next Year

$2.83

↓ 4.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PFE EPS of $2.96 for the current fiscal year, based on estimates from 15 analysts. The PFE revenue forecast is $61.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The PFE stock forecast is supported by two independent data sources: analyst consensus ratings from 39 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PFE price target is $27.00 (+5.0% upside), with an analyst consensus of Hold.

The PFE short-term stock prediction for tomorrow is $25.60 (-0.40%). The PFE stock price prediction for 2027 estimates an average of $21. The PFE stock prediction for 2030 projects a range of $16–$17.

Pfizer Inc. trades on NYSE under the ticker PFE. The PFE stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 41% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

PFE forecast · 8 questions

According to 39 Wall Street analysts, the average 12-month PFE price target is $27.00, with a high forecast of $30.00 and a low of $25.00. The median price target is shown in the chart above when available. This implies +5.0% potential upside from the current price of $25.70.

PFE price targetWhat is PFE price targetPFE analyst price targetPFE 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.